Clinical trials are research studies that are designed to determine if a new drug is safe and effective for patients. The FDA and medical experts agree that the best way for patients to obtain access to new drugs before they are approved in the United States is through participation in a clinical trial.
Featured Clinical Trials
Neuropathic Cancer Pain
ADV502 NCP
A Phase 2 multi-center clinical trial to evaluate the safety and efficacy of ADV502 compared to placebo for subjects with treatment-refractory Neuropathic Cancer Pain.
Further inclusion and exclusion criteria and other information about the study including contact details will be available here.
Completed Clinical Trials
SIMU-101
SIMU-101
An exploratory, randomized, double-blind, placebo, and active therapy-controlled, Phase 1 study, to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect of single and multiple ascending oral doses of ADV502 in healthy adults.
To find out if a clinical trial exists for a specific medicine or for a particular disease, visit clinicaltrials.gov.